Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Mesa Laboratories (MLAB) over the last 15 years, with Q4 2025 value amounting to $15.5 million.

  • Mesa Laboratories' Accumulated Expenses fell 3679.53% to $15.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $15.5 million, marking a year-over-year decrease of 3679.53%. This contributed to the annual value of $24.6 million for FY2025, which is 9132.84% up from last year.
  • Mesa Laboratories' Accumulated Expenses amounted to $15.5 million in Q4 2025, which was down 3679.53% from $14.2 million recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' Accumulated Expenses ranged from a high of $24.6 million in Q4 2024 and a low of $8.8 million during Q3 2021
  • In the last 5 years, Mesa Laboratories' Accumulated Expenses had a median value of $13.4 million in 2021 and averaged $15.0 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 10633.2% in 2024, then crashed by 3779.85% in 2025.
  • Mesa Laboratories' Accumulated Expenses (Quarter) stood at $14.0 million in 2021, then fell by 9.78% to $12.6 million in 2022, then rose by 26.02% to $15.9 million in 2023, then surged by 54.8% to $24.6 million in 2024, then plummeted by 36.8% to $15.5 million in 2025.
  • Its Accumulated Expenses was $15.5 million in Q4 2025, compared to $14.2 million in Q3 2025 and $16.1 million in Q2 2025.